drugset / Trial / NCT04058899

Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics

NCT04058899

Phase 1/2 Unknown 120 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of the present study is to compare the effect of IV infusion 0.5 µg/kg dexmedetomidine and IV 0.1 mg/kg nalbuphine in preschool children for prevention of emergence agitation after adenotonsillectomy under sevoflurane anesthesia.

Timeline

Start
2019-03-05
Primary completion
2019-09
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Nalbuphine Small molecule 0.1 mg/kg Intravenous

Indications